Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;37(7):2009-2014.
doi: 10.1111/jocs.16514. Epub 2022 Apr 19.

Coronavirus 2019 (COVID-19) venovenous extracorporeal oxygenation: Single community hospital results and insights

James Lee West  1 , Andrew Nutting  1 , Brock Daughtry  1 , Andrew M Frey  1 , Clara T Nicolas  1 , Rayan Saab  1 , David H Sibley  1 , Joshua Smith  1 , Ronald Roan  1 , Michael Crain  1
Affiliations

Coronavirus 2019 (COVID-19) venovenous extracorporeal oxygenation: Single community hospital results and insights

James Lee West et al. J Card Surg. 2022 Jul.

Abstract

Background: The role of extracorporeal membrane oxygenation (ECMO) for patients with refractory respiratory failure due to coronavirus 2019 (COVID-19) is still unclear even now over a year into the pandemic. ECMO is becoming more commonplace even at smaller community hospitals. While the advantages of venovenous (VV) ECMO in acute respiratory distress syndrome (ARDS) from COVID-19 have not been fully determined, we believe the benefits outweighed the risks in our patient population. Here we describe all patients who underwent VV ECMO at our center.

Methods: All patients placed on ECMO at our center since the beginning of the pandemic, May 5, 2020, until February 20, 2021 were included in our study. All patients placed on ECMO during the time period described above were followed until discharge or death. The primary endpoint was in-hospital death. Secondary outcomes included discharge disposition, that is, whether patients were sent to a long-term acute care center (LTAC), inpatient rehabilitation, or went directly home.

Results: A total of 41 patients were placed on VV ECMO for refractory acute respiratory failure. Survival to discharge, the primary end point, was 63.4% (26/41). Inpatient mortality was 36.6% (15/41).

Conclusions: We show here that a successful high-volume VV ECMO program for ARDS is achievable at even a medium-size community hospital. We think our success can be replicated by most small- and medium-size community hospitals with cardiothoracic surgery programs and intensivist teams.

Keywords: COVID-19; ECMO; critical care.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Outcomes of patients initiated on VV ECMO for COVID‐19. ECMO, extracorporeal membrane oxygenation; VV, venovenous.
See this image and copyright information in PMC

References

    1. Barbaro RP, MacLaren G, Boonstra PS, Iwashyna TJ, Slutsky AS, Fan E. Extracorporeal membrane oxygenation support in COVID‐19: an international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020;396(10257):1071‐1078. - PMC - PubMed
    1. Shih E, DeMaio MJ, Squiers JJ, et al. Venovenous extracorporeal membrane oxygenation for patients with refractory coronavirus disease 2019 (COVID‐19): multicenter experience of referral hospitals in a large health care system. J Thorac Cardiovasc Surg. 2020;163(3):1071‐1079. - PMC - PubMed
    1. Badulak J, Antonini MV, Stead CM, et al. Extracorporeal membrane oxygenation for COVID‐19: updated 2021 guidelines from the Extracorporeal Life Support Organization. ASAIO J. 2021;67:485‐495. - PMC - PubMed
    1. Sanaiha Y, Bailey K, Downey P, et al. Trends in mortality and resource utilization for extracorporeal membrane oxygenation in the United States: 2008–2014. Surgery. 2019;165:381‐388. - PubMed
    1. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374:1351‐1363. - PubMed